Drugs in the Pipeline
AbbVie Seeks Approval of Upadacitinib for Ulcerative Colitis
The applications are supported by data from two 2two phase 3 induction studies and one 1 maintenance study.
Your search for tofacitinib returned 3 results
Drugs in the Pipeline
Phase 3 Study Update of Tofacitinib for Rheumatoid Arthritis
Pfizer announced results from two of its Phase 3 studies, ORAL Standard and Oral Step, of tofacitinib (CP-690,550) for the treatment of active rheumatoid arthritis.
Drugs in the Pipeline
Phase 3 Study of Tofacitinib for Rheumatoid Arthritis
Pfizer announced results from its Phase 3 study of tofacitinib, formerly known as tasocitinib, for the treatment of patients with rheumatoid arthritis (RA).
